Iuliia Zhelnina, Tatiana Baidina, Alexander Zhelnin, Tatiana Trushnikova, Elena Shishkina
Perm Regional Clinical Hospital, Perm, Russian Federation;
E.A. Vagner Perm State Medical University, Perm, Russian Federation;
Kirov State Medical University, Kirov, Russian Federation
Cite: Zhelnina I., Baidina T., Zhelnin A., Trushnikova T., Shishkina E. Polyneuropathy in Rheumatoid Arthritis (literature review). JDAH 5(2), 47-54, (2024). https://doi.org/10.33847/2712-8149.5.2_5
Abstract. Rheumatoid arthritis is the most common rheumatological disease. In addition to joint pathology, it often causes damage of other organs and tissues. This article discusses the possibility of diffuse damage of the peripheral nervous system in rheumatoid arthritis – frequency, mechanisms of damage, peculiarities of the clinical symptoms. The relevance of this problem is due to the possibility of subclinical course of polyneuropathy in rheumatoid arthritis, and, consequently, the lack of diagnosis, while one of its variants – autonomic neuropathy, is a life-threatening pathology. In the presence of pain in the clinical picture of polyneuropathy, problems arise in its interpretation (neuropathic, nociceptive – joint pain), and, therefore, errors in dose adjustment of disease-modifying drugs are possible. For neurologists the problem of polyneuropathy in rheumatoid arthritis is interesting from the point of view of diagnosing the etiology of this disease, which is always a difficult task.
Keywords: rheumatoid arthritis, polyneuropathy, digital images.
References
1. Nasonov, E., Karateev, D., Balabanova, R. Rheumatoid arthritis. In: Rheumatology. National guidelines. Moscow: GEOTAR-Media (2008).
2. Rheumatoid arthritis. Clinical guidelines of the Russian Federation (2021). https://diseases.medelement.com/disease/
3. Rheumatology: clinical guidelines / edited by Academician of the Russian Academy of Medical Sciences. Nasonov, E. 2nd ed. Moscow: GEOTAR-Media (2010).
4. McWilliams D., Walsh D.: Pain mechanisms in rheumatoid arthritis. Clin Exp Rheumatol. 107(5), 94-101 (2017).
5. Mathias, K., Amarnani, A., Pal, N. et al.: Chronic Pain in Patients with Rheumatoid Arthritis. Curr Pain Headache Rep. 25(9), 59 (2021).
6. Dubois-Mendes, S., Meneses, F., De Andrade D.: Neuropathic pain in rheumatoid arthritis and its association with Afro-descendant ethnicity: a hierarchical analysis. Psychology, Health & Medicine 26(3), 278-288 (2021).
7. Li, Y., Jiang, L., Zhang, Z., et al.:Clinical characteristics of rheumatoid arthritis patients with peripheral neuropathy and potential related risk factors. Clin Rheumatol. 38(8), 2099-2107 (2019).
8. Levin, O.: General approaches to the treatment of polyneuropathies. Modern therapy in psychiatry and neurology 1, 4-12 (2018).
9. Sommer, C., Geber, C., Young, P., et. al.: Polyneuropathies. Dtsch Arztebl Int. 115(6), 83-90 (2018) .
10. Kaeley, N., Ahmad, S., Pathania, M., Kakkar, R. :Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prime Care 8, 22–6 (2019).
11. Kumar, B., Das, M., Misra, A.: A cross-sectional study of association of serostatus and extra-articular manifestations in patients with rheumatoid arthritis in a teaching hospital. J Family Med Prime Care 9, 2789–93 (2020).
12. Agarwal, V., Singh, R., Wiclaf et al.: A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 27(7), 841-4 (2008).
13. Bayrak, A., Durmus, D., Durmaz, Y., et al.: Electrophysiological assessment of polyneuropathic involvement in rheumatoid arthritis: relationships among demographic, clinical and laboratory findings. Neurol Res. 32(7), 711-4 (2010).
14. Prevoo, M., van’t Hof, M., Kuper, H. et al.: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38(1), 44-8 (1995).
15. Ziegler, D., Keller, J., Maier, C. et al.: Diabetische Neuropathie. Diabetologie und Stoffwechsel. 14(2), 243-257 (2019).
16. Li, Y., Jiang, L., Zhang, Z. et al.: Clinical characteristics of rheumatoid arthritis patients with peripheral neuropathy and potential related risk factors. Clin Rheumatol. 38(8), 2099-2107 (2019).
17. Weller, R., Bruckner, F., Chamberlain, M.: Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 33(5), 592-604 (1970).
18. Ding, Y., Zhang, L., Zeng, H., Liu, S. Clinical analysis of 46 rheumatoid arthritis patients with peripheral neuropathy. Zhonghua Nei Ke Za Zhi. 60(3), 222-226 (2021).
19. Karaca Umay, E., Gurcay, E., Karsli, P. et al.: Sensory disturbance and polyneuropathy in rheumatoid arthritis patients with foot deformity. Rev Bras Reumatol Engl Ed. 56(3), 191-7 (2016).
20. Kaeley, N., Ahmad, S., Pathania, M., Kakkar, R.: Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prime Care 8(1), 22-26 (2019).
21. Biswas, M., Chatterjee, A., Ghosh, S. et al.: Prevalence, types, clinical associations, and determinants of peripheral neuropathy in rheumatoid patients. Ann Indian Acad Neurol. 14, 194–7 (2011).
22. Sim, M., Kim, D., Yoon, J., et al.: Assessment of peripheral neuropathy in patients with rheumatoid arthritis who complain of neurologic symptoms. Ann Rehabil Med. 38,249–55 (2014).
23. Joaquim, .F, Appenzeller, S.: Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev. 14(12), 1116-22 (2015).
24. Ramos-Remus, C., Duran-Barragan, S., Castillo-Ortiz, J.: Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol. 31(1), 1-12 (2012).
25. Ropper, A., Samuels, M., Klein, J.: (2014). Asymmetrical and Multifocal Polyneuropathies (Mononeuropathy, or Mononeuritis Multiplex). Adams and Victor’s Principles of Neurology. 10th Edn: McGraw-Hill Education Medical 1341–1343 (2014).
26. Bril, V., Katzberg, H.:. Acquired immune axonal neuropathies, Continuum (Minneap Minn). 20 (5 Peripheral Nervous System Disorders), 1261–1273 (2014).
27. Kaeley, N., Ahmad, S., Pathania., M, Kakkar, R.: Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prime Care 8, 22–6 (2019).
28. Bekkelund, S., Torbergsen, T., Husby G., Mellgren, S. Myopathy and neuropathy in rheumatoid arthritis. A quantitative controlled electromyographic study. J Rheumatol. 26, 2348–51 (1999).
29. Naum, R., Gwathmey, K.: Autoimmune polyneuropathies. Handb Clin Neurol. 195, 587-608 (2023).
30. Agarwal, V., Singh, R., Wiclaf et al.: A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 27(7), 841-4 (2008).
31. Report and recommendations of the San Antonio conference on diabetic neuropathy. Ann Neurol. 24(1), 99-104 (1988).
33. Tkacheva, O., Vertkin, A.: Diabetic autonomic neuropathy. M.: GEOTAR – Media. – 176 (2009).
34. Adlan, A., Lip, G., Paton, J. et al.: Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum. 44(3), 283-304 (2014).
35. Provan, S., Olstad, D., Solberg, E. et al.: Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: A meta-analyses study. Semin Arthritis Rheum. 48(1),134-140 (2018).
36. Kosek, E., Altawil, R., Kadetoff, D. et al.: Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain–interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis. J Neuroimmunol. 280, 49-55 (2015).
37. Anichkov, D., Shostak, N., Ivanov. D.: Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients. Int J Clin Pract. 61, 777-83 (2007).
38. Biswas, M., Chatterjee, A., Ghosh, S. et al.: Prevalence, types, clinical associations, and determinants of peripheral neuropathy in rheumatoid patients. Ann. Indian Acad. Neurol. 14, 194–197 (2011).
39. De Souza, J., Trevisan, T., Sepresse, R. et al.: Peripheral Neuropathy in Systemic Autoimmune Rheumatic Diseases-Diagnosis and Treatment. Pharmaceuticals (Basel) 16(4), 587 (2023).
40. Devigili, G., Tugnoli, V., Penza, P. et al.: The diagnostic criteria for small fiber neuropathy: From symptoms to neuropathology. Brain 131, 1912–1925 (2008).
41. Tulbă, D., Popescu, B., Manole, E., Băicuș, C.: Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases. Front Pharmacol. 14, 12 (2021).
42. Zaottini, F., Picasso, R., Pistoia, F. et al.: High-resolution ultrasound of peripheral neuropathies in rheumatological patients: An overview of clinical applications and imaging findings. Front Med (Lausanne) 31, 9 (2022).
43. Ishibe K., Tamatsu Y., Miura M., Shimada K. Morphological study of the vasa nervorum in the peripheral branch of human facial nerve. Okajimas Folia Anat. Jpn. 88(3), 111–119 (2011).
44. Mizisin, A., Weerasuriya, A.: Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol. 121(3), 291–312 (2011)
45. Cojocaru. I., Cojocaru, M., Silosi, I., Vrabie, C.: Peripheral nervous system manifestations in systemic autoimmune diseases. Maedica (Bucur) 9(3), 289-94 (2014).
46. Sampaio L., Silva L. G., Terroso G. et al.. Vasculitic neuropathy. Acta Reumatol Port. 36(2), 102–109 (2011).
47. Collins, M., Arnold, W., Kissel, J.: The neuropathies of vasculitis. Neurol. Clin. 31(2), 557–595, (2013).
48. Bril, V., Katzberg, H.: Acquired immune axonal neuropathies. Continuum (Minneap Minn). 20(5 Peripheral Nervous System Disorders), 1261-73 (2014).
49. Vallat, J., Vita, l., Magy, L. at al.: An update on nerve biopsy. J Neuropathol Exp Neurol. 68(8), 833-44 (2009).
50. Bril, V., England, J., Franklin, G. et al.: Evidence-based guideline: treatment painful diabetic neuropathy: a report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76 (20), 1758–1765 (2011).
51. Snoussi, M., Frickha, F. , Bahloul, Z.: Peripheral neuropathy in connective tissue diseases, in Demystifying polyneuropathy: IntechOpen. Editor Ambrosi, P., 568 (2019).
52. De Souza, J., Trevisan, T., Sepresse, S. et al.: Peripheral Neuropathy in Systemic Autoimmune Rheumatic Diseases-Diagnosis and Treatment. Pharmaceuticals (Basel) 16(4), 587 (2023).
53. Rajeshwari, B., Kumar, S.: Rheumatoid Neuropathy: A Brief Overview. Cureus 15(1), 34127 (2023).
54. Uceyler, N., Kafke, W., Riediger, N., He, L. et al.: Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74, 1806–1813 (2010).
55. Hoeijmakers J., Faber C., Lauria G., Merkies I., Waxman S.: Small-fiber neuropathies—Advances in diagnosis, pathophysiology and management. Nat. Rev. Neurol. 8, 369–379 (2012).
56. Birnbaum, J., Lalji, A., Saed, A., Baer, A.: Biopsy-proven small-fiber neuropathy in primary Sjögren’s syndrome: Neuropathic pain characteristics, autoantibody findings, and histopathologic features. Arthritis Care Res. 71, 936–948 (2019).
57. Burgess, J., Ferdousi, M., Gosal, D.: Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther. 9(2), 385-450 (2021).
55. Muanda, F., Blake, P., Weir, M. et al.: Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease. JAMA Netw Open. 6(11), 2345132 (2023).
59. Perricone, C., Castellucci, A., Cafaro, G.: Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy. Front Immunol. 24, 15 (2024).
60. Gartlehner, G., Hansen, R., Jonas, B. et al.: The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol. 33, 2398–408 (2006).
61. Delcoigne, B., Kopp, T., Arkema, E. et al.: Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD Open. 9(1), (2023).
Published online 23.12.2024
